Analysis of the tensile strength on the healing of the abdominal wall of rats treated with infliximab

Acta Cirurgica Brasileira

Volumn 23, Issue 5, 2008, Pages 441-446

  Lopes, João Vieira ^a,c   De Freitas, Luís Alberto Mendonça ^b   Marques, Ravi Dias ^a   Bocca, Anamélia Lorenzetti ^a   De Sousa, João Batista ^a   De Oliveira, Paulo Gonçalves ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b Education and Research in Health Sciences Foundation   (Brazil)

^c Bl C/203 ^*  (Brazil)

Author keywords

Abdominal wall; Antibodies, monoclonal; Rats; Wound healing

Indexed keywords

INFLIXIMAB; NYLON; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL WALL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DYNAMOMETER; EUTHANASIA; MALE; NONHUMAN; POSTOPERATIVE PERIOD; RAT; REOPERATION; SURGICAL WOUND; SUTURE; TENSILE STRENGTH; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 53249086407     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/s0102-86502008000500009     Document Type: Article

References (24)

1. Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Infliximabe. In: Compêndio de Bulas de Medicamentos. Brasília: Ed. ANVISA; 2004/2005.p.2330-44.
2. Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P, et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol. 1993;30(16):1443-53.
3. Siegel SA, Shealy DJ, Nakada MT, Le J, Woulfe DS, Probert L, Kollias G, Ghrayeb J, Vilcek Daddona PE. The mouse/human chimeric monoclonal antibody Ca2 neutralizes TNF in vitro and protects transgenic mice From cachexia and TNF lethality in vivo. Cytokine. 1995;7 (1):15-25.
4. Scallon BJ, Moore MA, Trinh H, Knight DM, Ghrayeb J. Chimeric anti-TNF-Alpha monoclonal antibody Ca2 binds recombinant transmembrane TNF-Alpha and activates immune effector functions. Cytokine. 1995;7(3):251-9.
5. Sandborn WJ. Optmizing anti-tumor necrosis factor strategies in inflamatory bowel disease. Curr Gastroenterol Rep. 2003;5(6):501-5.
6. Danese S, Semeraro, S, Armuzzi A, Papa A, Gasbarrini A. Biological therapies for inflammatory bowel disease: research drives clinics. Mini Rev Med Chem. 2006;6(7):771-84.
7. Carrico TJ, Mehrhof AI, Cohen IK. Biology of wound healing. Surg Clin North Am. 1984;64:721-32.
8. Sousa JB, Soares EG, Aprilli F. Effects of diclofenac sodium on intestinal anastomotic healing: experimental study on the small intestine of rabbits. Dis Colon Rectum. 1991;34(7):613-7.
9. Eubanks TR, Greenberg JJ, Dobrin PB, Harford FJ, Gamelli RL. The effect of different corticosteroids on the healing colon anastomosis and cecum in a rat model. Am Surg. 1997;63:266-9.
10. Sirimarco MT. Estudo comparativo dos efeitos de dois corticosteró ides sintéticos, deflazacort e predinisona, na cicatrização de anastomoses colônicas de ratos [Doutorado]. Universidade de São Paulo: Faculdade de Medicina de Ribeirão Preto; 2000.
11. Gogia, PP. Clinical wound management. USA: Slack Incorporated; 1995.
12. Mantzoros I, Kanellos I, Angelopoulos S, Koliakos G, Pramateftakis, MG, Kanellos D, Zacharakis E, Zaraboukas T, Betsis D. The effect of insulin-like growth factor I on healing of colonic anastomoses in cortisone-treated rats. Dis Colon Rectum. 2006;49(9):1431-8.
13. Minossi JG, Leite CVS, Naresse LE, Rodrigues MAM, Angeleli AYO, Kobayasi S. Sodium diclofenac effect in abdominal wound healing in rats: histological, breaking strength e tissue collagen studies. Acta Cir Bras. 2001;16(3):146-54.
14. Streit M, Beleznay Z, Braathen LR. Topical application of tumor necrosis factor-alpha antibody infliximab improves healing of chronic wounds. Int Wound J. 2006;3(3):171-9.
15. Mezadri TJ, Tomáz VA, Amaral VLL. Animais de laboratório: cuidados na iniciação experimental. Santa Catarina: Editora da UFSC; 2004.
16. Lopes JV, Oliveira PG, Sousa JB, Báo SN, Takano GHS, Leal IIR. Histopathologic evaluation of the peritoneum exposed to heat shock: experimental study in rats. Acta Cir Bras. 2007;22(5):342-50. Available from URL: http://www.scielo.br/acb
17. 1 analog, on the healing of colonic anastomoses in rats. Dis Colon Rectum. 1994;37(7):660-3.
18. Freitas LAM. Avaliação dos efeitos do anticorpo monoclonal, infliximabe, na cicatrização de anastomoses colônicas: estudo experimental em ratos. [Mestrado]. Brasília: Universidade de Brasília, Faculdade de Medicina; 2007.
19. Rossi LF, Ramos RR, Ely JB, Kestering DM, Soldi MS, Brum SPB, d'Acampora AJ. Considerations that may infl uence the result of trials assessing tensile strength in experimental surgery. Acta Cir Bras. 2007;22(6):73-7.
20. Oliveira PG, Sousa JB, Reys LGCV, Magalhães AV, Rabelo FS, Muniz KC. Effects of enoxaparin on the healing of abdominal wall in rats: study on breaking strength and histopatology. Acta Cir Bras. 2006;21(4):247-51. Available from URL: http://www.scielo.br/acb
21. Gonçalves CG, Coelho JCU, Amarante HMBS. Obstrução intestinal após uso de infliximabe no tratamento de fístula êntero-cutânea na doença de Crohn. Rev Col Bras Cir. 2005;32(4):223-4.
22. Martin P, Medeiros AC, Goldennstein-Schainberg C. The role of tumor necrois factor inhibitors in the treatment of junvenile idiopatic arthritis. Rev Bras Reumatol. 2006;46(2):126-33.
23. Souza AWS, Pileggi P, Hachbarth ET. Tratamento com infliximabe da doença de Behçet ativa. Rev Bras Reumatol. 2005;45(2):91-3.
24. van der Hagen SJ, Baeten CG, Soeters PB, Russel MG, Beets-Tan RG van Gemert WG. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definite surgery of complex anal fistulas in Crohn's disease: a preliminary report. Dis Colon Rectum. 2005;48(4):758-67.